Altered Mental Status in the Solid-Organ Transplant Recipient

Abstract

Patients undergoing solid-organ transplantation (SOT) face a tumultuous journey. Prior to transplant, their medical course is characterized by organ dysfunction, diminished quality of life, and reliance on organ support, all of which are endured in hopes of reaching the haven of organ transplantation. Peritransplant altered mental status may indicate neurologic insults acquired during transplant and may have long-lasting consequences. Even years after transplant, these patients are at heightened risk for neurologic dysfunction from a myriad of metabolic, toxic, and infectious causes. This review provides a comprehensive examination of causes, diagnostic approaches, neuroimaging findings, and management strategies for altered mental status in SOT recipients. Given their complexity and the numerous etiologies for neurologic dysfunction, liver transplant patients are a chief focus in this review; however, we also review lesser-known contributors to neurological injury across various transplant types. From hepatic encephalopathy to cerebral edema, seizures, and infections, this review highlights the importance of recognizing and managing pre- and posttransplant neurological complications to optimize patient outcomes.

Keywords

altered mental status - solid-organ transplant - hepatic encephalopathy - hyperammonemia - white matter lesions - acute liver failure - calcineurin inhibitor toxicity - cognitive dysfunction - donor-derived infection - air embolism

^* N.W. and H.P. are co–first authors. Both authors contributed equally to the manuscript.

Publikationsverlauf

Artikel online veröffentlicht:
24. August 2024

• References

• 1 DiMartini A, Chopra K. The importance of hepatic encephalopathy: pre-transplant and post-transplant. Liver Transpl 2009; 15 (02) 121-123
• 2 Ott P, Vilstrup H. Cerebral effects of ammonia in liver disease: current hypotheses. Metab Brain Dis 2014; 29 (04) 901-911
• 3 Cordoba J, Blei AT. Brain edema and hepatic encephalopathy. Semin Liver Dis 1996; 16 (03) 271-280
• 4 Rangroo Thrane V, Thrane AS, Wang F. et al. Ammonia triggers neuronal disinhibition and seizures by impairing astrocyte potassium buffering. Nat Med 2013; 19 (12) 1643-1648
• 5 Wright G, Noiret L, Olde Damink SW, Jalan R. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies. Liver Int 2011; 31 (02) 163-175
• 6 Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013; 369 (26) 2525-2534
• 7 Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007; 46 (06) 1844-1852
• 8 Chen D, Kandiah P, Karakis I, Perez-Rodriguez R, Haider H, Rodriguez-Ruiz A. Continuous EEG in Acute Liver Failure: Findings and Prognostic Value. Nashville, TN:: American Society of Epilepsy;; 2022
• 9 Stravitz RT, Ellerbe C, Durkalski V. et al; Acute Liver Failure Study Group. Bleeding complications in acute liver failure. Hepatology 2018; 67 (05) 1931-1942
• 10 Karvellas CJ, Fix OK, Battenhouse H, Durkalski V, Sanders C, Lee WM. U S Acute Liver Failure Study Group. Outcomes and complications of intracranial pressure monitoring in acute liver failure: a retrospective cohort study. Crit Care Med 2014; 42 (05) 1157-1167
• 11 Maloney PR, Mallory GW, Atkinson JL, Wijdicks EF, Rabinstein AA, Van Gompel JJ. Intracranial pressure monitoring in acute liver failure: institutional case series. Neurocrit Care 2016; 25 (01) 86-93
• 12 Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ. US Acute Liver Failure Study Group. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology 2018; 67 (02) 711-720
• 13 Warrillow S, Fisher C, Tibballs H. et al; Australasian Management of Acute Liver Failure Investigators (AMALFI). Continuous renal replacement therapy and its impact on hyperammonaemia in acute liver failure. Crit Care Resusc 2020; 22 (02) 158-165
• 14 Murphy N, Auzinger G, Bernel W, Wendon J. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39 (02) 464-470
• 15 Larsen FS, Schmidt LE, Bernsmeier C. et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 2016; 64 (01) 69-78
• 16 Stahl K, Hadem J, Schneider A. et al. Therapeutic plasma exchange in acute liver failure. J Clin Apher 2019; 34 (05) 589-597
• 17 Kalal CR, Maiwall R, Choudhary A. et al. Mannitol is comparable to hypertonic saline for raised intracranial pressure in acute liver failure (MAHAL Study): a randomized controlled trial. Dig Dis 2022; 40 (05) 607-615
• 18 Rose CF, Amodio P, Bajaj JS. et al. Hepatic encephalopathy: novel insights into classification, pathophysiology and therapy. J Hepatol 2020; 73 (06) 1526-1547
• 19 Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT. Hepatic encephalopathy–definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35 (03) 716-721
• 20 European Association for the Study of the Liver. Electronic address: [e-mail], European Association for the Study of the Liver. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. J Hepatol 2022; 77 (03) 807-824
• 21 Weissenborn K. Portosystemic encephalopathy. Handb Clin Neurol 2014; 120: 661-674
• 22 Nicolao F, Efrati C, Masini A, Merli M, Attili AF, Riggio O. Role of determination of partial pressure of ammonia in cirrhotic patients with and without hepatic encephalopathy. J Hepatol 2003; 38 (04) 441-446
• 23 Gundling F, Zelihic E, Seidl H. et al. How to diagnose hepatic encephalopathy in the emergency department. Ann Hepatol 2013; 12 (01) 108-114
• 24 Inoue E, Hori S, Narumi Y. et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991; 179 (02) 551-555
• 25 Zeneroli ML, Cioni G, Crisi G, Vezzelli C, Ventura E. Globus pallidus alterations and brain atrophy in liver cirrhosis patients with encephalopathy: an MR imaging study. Magn Reson Imaging 1991; 9 (03) 295-302
• 26 Lim CG, Hahm MH, Lee HJ. Hepatic encephalopathy on magnetic resonance imaging and its uncertain differential diagnoses: a narrative review. J Yeungnam Med Sci 2023; 40 (02) 136-145
• 27 Pflugrad H, Bronzlik P, Raab P. et al. Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?. Liver Int 2015; 35 (07) 1816-1823
• 28 Alonso J, Córdoba J, Rovira A. Brain magnetic resonance in hepatic encephalopathy. Semin Ultrasound CT MR 2014; 35 (02) 136-152
• 29 Rovira A, Mínguez B, Aymerich FX. et al. Decreased white matter lesion volume and improved cognitive function after liver transplantation. Hepatology 2007; 46 (05) 1485-1490
• 30 Arnold SM, Els T, Spreer J, Schumacher M. Acute hepatic encephalopathy with diffuse cortical lesions. Neuroradiology 2001; 43 (07) 551-554
• 31 Weiss N, Thabut D. Ammonia rises from the ashes!. JHEP Rep Innov Hepatol 2022; 4 (11) 100559
• 32 Kandiah PA, Kumar G. Hepatic encephalopathy-the old and the new. Crit Care Clin 2016; 32 (03) 311-329
• 33 Guo RM, Li QL, Zhong LR. et al. Brain MRI findings in acute hepatic encephalopathy in liver transplant recipients. Acta Neurol Belg 2018; 118 (02) 251-258
• 34 Kreis R, Ross BD, Farrow NA, Ackerman Z. Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 1992; 182 (01) 19-27
• 35 Rudler M, Weiss N, Bouzbib C, Thabut D. Diagnosis and management of hepatic encephalopathy. Clin Liver Dis 2021; 25 (02) 393-417
• 36 Laleman W, Simon-Talero M, Maleux G. et al; EASL-CLIF-Consortium. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology 2013; 57 (06) 2448-2457
• 37 Crismale JF, Meliambro KA, DeMaria Jr S, Bronster DB, Florman S, Schiano TD. Prevention of the osmotic demyelination syndrome after liver transplantation: a multidisciplinary perspective. Am J Transplant 2017; 17 (10) 2537-2545
• 38 Agildere AM, Başaran C, Cakir B, Ozgül E, Kural F, Haberal M. Evaluation of neurologic complications by brain MRI in kidney and liver transplant recipients. Transplant Proc 2006; 38 (02) 611-618
• 39 Balcerac A, Nichelli L, Demeret S, Le Guennec L. The piglet and the trident sign in osmotic demyelination syndrome. Intensive Care Med 2021; 47 (04) 476-477
• 40 Crismale JF, Huisman T, Deshpande R. et al. A protocol for the management of hyponatremia peri-liver transplant reduces post-transplant neurological complications. Clin Transplant 2021; 35 (05) e14276
• 41 Hoorn EJ, Zietse R. Diagnosis and treatment of hyponatremia: compilation of the guidelines. J Am Soc Nephrol 2017; 28 (05) 1340-1349
• 42 Louis G, Megarbane B, Lavoué S. et al. Long-term outcome of patients hospitalized in intensive care units with central or extrapontine myelinolysis*. Crit Care Med 2012; 40 (03) 970-972
• 43 Cordoba J, Ventura-Cots M, Simón-Talero M. et al; CANONIC Study Investigators of EASL-CLIF Consortium. Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). J Hepatol 2014; 60 (02) 275-281
• 44 Joshi D, O'Grady J, Patel A. et al. Cerebral oedema is rare in acute-on-chronic liver failure patients presenting with high-grade hepatic encephalopathy. Liver Int 2014; 34 (03) 362-366
• 45 Jalan R, Dabos K, Redhead DN, Lee A, Hayes PC. Elevation of intracranial pressure following transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 1997; 27 (05) 928-933
• 46 Currie CJ, Poole CD, Evans M, Peters JR, Morgan CL. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab 2013; 98 (02) 668-677
• 47 Hamed SA. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. Expert Rev Clin Pharmacol 2019; 12 (01) 61-90
• 48 Seifter JL, Samuels MA. Uremic encephalopathy and other brain disorders associated with renal failure. Semin Neurol 2011; 31 (02) 139-143
• 49 Havakuk O, King KS, Grazette L. et al. Heart failure-induced brain injury. J Am Coll Cardiol 2017; 69 (12) 1609-1616
• 50 Kim W, Kim EJ. Heart failure as a risk factor for stroke. J Stroke 2018; 20 (01) 33-45
• 51 Kato TS, Schulze PC, Yang J. et al. Pre-operative and post-operative risk factors associated with neurologic complications in patients with advanced heart failure supported by a left ventricular assist device. J Heart Lung Transplant 2012; 31 (01) 1-8
• 52 Puteikis K, Mameniškienė R, Jurevičienė E. Neurological and psychiatric comorbidities in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2021; 16: 553-562
• 53 Gamez J, Salvado M, Martinez-de La Ossa A. et al. Influence of early neurological complications on clinical outcome following lung transplant. PLoS One 2017; 12 (03) e0174092
• 54 Bernhardt M, Pflugrad H, Goldbecker A. et al. Central nervous system complications after liver transplantation: common but mostly transient phenomena. Liver Transpl 2015; 21 (02) 224-232
• 55 Martins PN, Buchwald JE, Mergental H, Vargas L, Quintini C. The role of normothermic machine perfusion in liver transplantation. Int J Surg 2020; 82S: 52-60
• 56 Mazzoni G, Koep L, Starzl T. Air embolus in liver transplantation. Transplant Proc 1979; 11 (01) 267-268
• 57 Dilip M, Bielawski A, Owen E. Hyperbaric oxygen therapy for cerebral air gas embolism following orthotopic heart transplant: case report. Undersea Hyperb Med 2018; 45 (06) 685-688
• 58 Sotil EU, Gottstein J, Ayala E, Randolph C, Blei AT. Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation. Liver Transpl 2009; 15 (02) 184-192
• 59 Pflugrad H, Tryc AB, Goldbecker A. et al. Hepatic encephalopathy before and neurological complications after liver transplantation have no impact on the employment status 1 year after transplantation. World J Hepatol 2017; 9 (10) 519-532
• 60 Balderramo D, Prieto J, Cárdenas A, Navasa M. Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor-induced neurotoxicity after liver transplantation. Transpl Int 2011; 24 (08) 812-819
• 61 Dhar R, Young GB, Marotta P. Perioperative neurological complications after liver transplantation are best predicted by pre-transplant hepatic encephalopathy. Neurocrit Care 2008; 8 (02) 253-258
• 62 Rolando N, Harvey F, Brahm J. et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol 1991; 12 (01) 1-9
• 63 Belicard F, Pinceaux K, Le Pabic E. et al. Bacterial and fungal infections: a frequent and deadly complication among critically ill acute liver failure patients. Infect Dis (Lond) 2023; 55 (07) 480-489
• 64 Nanchal R, Subramanian R, Alhazzani W. et al. Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU: neurology, peri-transplant medicine, infectious disease, and gastroenterology considerations. Crit Care Med 2023; 51 (05) 657-676
• 65 Oehler D, Oehler H, Sigetti D. et al. Early postoperative neurologic events are associated with worse outcome and fatal midterm survival after adult heart transplantation. J Am Heart Assoc 2023; 12 (16) e029957
• 66 Belvís R, Martí-Fàbregas J, Cocho D. et al. Cerebrovascular disease as a complication of cardiac transplantation. Cerebrovasc Dis 2005; 19 (04) 267-271
• 67 Pérez-Miralles F, Sánchez-Manso JC, Almenar-Bonet L, Sevilla-Mantecón T, Martínez-Dolz L, Vílchez-Padilla JJ. Incidence of and risk factors for neurologic complications after heart transplantation. Transplant Proc 2005; 37 (09) 4067-4070
• 68 Le Guennec L, Shor N, Levy B. et al. Spinal cord infarction during venoarterial-extracorporeal membrane oxygenation support. J Artif Organs 2020; 23 (04) 388-393
• 69 Le Guennec L, Bertrand A, Laurent C. et al. Diffuse cerebral microbleeds after extracorporeal membrane oxygenation support. Am J Respir Crit Care Med 2015; 191 (05) 594-596
• 70 Le Guennec L, Cholet C, Huang F. et al. Ischemic and hemorrhagic brain injury during venoarterial-extracorporeal membrane oxygenation. Ann Intensive Care 2018; 8 (01) 129
• 71 Lin P, Tian X, Wang X. Seizures after transplantation. Seizure 2018; 61: 177-185
• 72 Shepard PW, St Louis EK. Seizure treatment in transplant patients. Curr Treat Options Neurol 2012; 14 (04) 332-347
• 73 Wijdicks EF, Plevak DJ, Wiesner RH, Steers JL. Causes and outcome of seizures in liver transplant recipients. Neurology 1996; 47 (06) 1523-1525
• 74 Keown PA, Laupacis A, Carruthers G. et al. Interaction between phenytoin and cyclosporine following organ transplantation. Transplantation 1984; 38 (03) 304-306
• 75 Chabolla DR, Wszolek ZK. Pharmacologic management of seizures in organ transplant. Neurology 2006; 67 (12, suppl 4): S34-S38
• 76 Grigg MM, Costanzo-Nordin MR, Celesia GG. et al. The etiology of seizures after cardiac transplantation. Transplant Proc 1988; 20 (3, suppl 3): 937-944
• 77 Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol 2015; 14 (09) 914-925
• 78 Roth C, Ferbert A. The posterior reversible encephalopathy syndrome: what's certain, what's new?. Pract Neurol 2011; 11 (03) 136-144
• 79 Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008; 29 (06) 1036-1042
• 80 Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008; 29 (06) 1043-1049
• 81 Rompianesi G, Montalti R, Cautero N. et al. Neurological complications after liver transplantation as a consequence of immunosuppression: univariate and multivariate analysis of risk factors. Transpl Int 2015; 28 (07) 864-869
• 82 DiMartini A, Fontes P, Dew MA, Lotrich FE, de Vera M. Age, model for end-stage liver disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity. Liver Transpl 2008; 14 (06) 815-822
• 83 Yamauchi A, Ieiri I, Kataoka Y. et al. Neurotoxicity induced by tacrolimus after liver transplantation: relation to genetic polymorphisms of the ABCB1 (MDR1) gene. Transplantation 2002; 74 (04) 571-572
• 84 Rivillas JA, Galindo-Coral S, Arias-Mora F. et al. Posterior reversible encephalopathy syndrome associated with tacrolimus in cardiac transplantation. Case Rep Cardiol 2021; 2021: 9998205
• 85 Ramirez R, Muskula PR, Everley MP. Posterior reversible encephalopathy syndrome after orthotopic heart transplantation: a case report. Am J Case Rep 2017; 18: 487-490
• 86 Kumai Y, Seguchi O, Sato T. et al. Reversible cerebral vasoconstriction syndrome after heart transplantation: a case report. Transplant Proc 2017; 49 (10) 2415-2418
• 87 Yamagishi H, Chen-Yoshikawa TF, Date H. Basiliximab for posterior reversible encephalopathy syndrome after lung transplantation. Eur J Cardiothorac Surg 2017; 52 (04) 823-824
• 88 Srichawla BS, Quast J. Magnesium deficiency: an overlooked key to the puzzle of posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS)?. J Neurol Sci 2023; 453: 120796
• 89 Magsi S, Zafar A. Malignant posterior reversible encephalopathy syndrome - an exacting challenge for neurocritical care physicians. Neurohospitalist 2017; 7 (04) 196-199
• 90 Triplett JD, Kutlubaev MA, Kermode AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract Neurol 2022; 22 (03) 183-189
• 91 Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338 (24) 1741-1751
• 92 Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357 (25) 2601-2614
• 93 Timsit JF, Sonneville R, Kalil AC. et al. Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients. Intensive Care Med 2019; 45 (05) 573-591
• 94 Wright AJ, Fishman JA. Central nervous system syndromes in solid organ transplant recipients. Clin Infect Dis 2014; 59 (07) 1001-1011
• 95 van den Bogaart L, Lang BM, Rossi S. et al; Swiss Transplant Cohort Study. Central nervous system infections in solid organ transplant recipients: Results from the Swiss Transplant Cohort Study. J Infect 2022; 85 (01) 1-7
• 96 van Veen KE, Brouwer MC, van der Ende A, van de Beek D. Bacterial meningitis in solid organ transplant recipients: a population-based prospective study. Transpl Infect Dis 2016; 18 (05) 674-680
• 97 Razonable RR, Zerr DM. AST Infectious Diseases Community of Practice. HHV-6, HHV-7 and HHV-8 in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl. 04) S100-S103
• 98 Malahe SRK, van Kampen JJA, Manintveld OC. et al. Current perspectives on the management of herpesvirus infections in solid organ transplant recipients. Viruses 2023; 15 (07) 1595
• 99 Penumarthi LR, La Hoz RM, Wolfe CR. et al. Cryptococcus transmission through solid organ transplantation in the United States: a report from the Ad Hoc Disease Transmission Advisory Committee. Am J Transplant 2021; 21 (05) 1911-1923
• 100 Fischer SA, Graham MB, Kuehnert MJ. et al; LCMV in Transplant Recipients Investigation Team. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 2006; 354 (21) 2235-2249
• 101 Soto RA, McDonald E, Annambhotla P. et al. West Nile Virus transmission by solid organ transplantation and considerations for organ donor screening practices, United States. Emerg Infect Dis 2022; 28 (02) 403-406
• 102 Kamar N, Selves J, Mansuy JM. et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358 (08) 811-817
• 103 Pouch SM, Katugaha SB, Shieh WJ. et al. Transmission of eastern equine encephalitis virus from an organ donor to three transplant recipients. Clin Infect Dis 2019; 69 (03) 450-458
• 104 Bharat A, Cunningham SA, Scott Budinger GR. et al. Disseminated Ureaplasma infection as a cause of fatal hyperammonemia in humans. Sci Transl Med 2015; 7 (284) 284re3
• 105 Kamel AY, Emtiazjoo AM, Adkins L. et al. Hyperammonemia after lung transplantation: systematic review and a mini case series. Transpl Int 2022; 35: 10433
• 106 Phillips SM, Pouch SM, Lo DJ. et al. A case of “cryptammonia”: disseminated cryptococcal infection generating profound hyperammonemia in a liver transplant recipient. J Investig Med High Impact Case Rep 2022; 10: 23 247096221129467
• 107 Fleming D, Patel R. Flurofamide prevention and treatment of Ureaplasma-induced hyperammonemia. Microbiol Spectr 2022; 10 (05) e0192722
• 108 Abad CLR, Bhaimia E, Schuetz AN, Razonable RR. A comprehensive review of Strongyloides stercoralis infection after solid organ and hematopoietic stem cell transplantation. Clin Transplant 2022; 36 (11) e14795
• 109 Adeyemo A, Montgomery S, Chancey RJ. et al. Investigation of donor-derived Strongyloides stercoralis infection in multiple solid organ transplant recipients-California, Michigan, Ohio, 2022. Transpl Infect Dis 2023; 25 (03) e14059
• 110 Mathon B, Favreau M, Degos V. et al; PSL BRAIN-BIOPSY STUDY GROUP. Brain Biopsy for Neurological Diseases of Unknown Etiology in Critically Ill Patients: Feasibility, Safety, and Diagnostic Yield. Crit Care Med 2022; 50 (06) e516-e525
• 111 Mathon B, Le Joncour A, Bielle F. et al; PSL Brain-Biopsy Study Group. Neurological diseases of unknown etiology: Brain-biopsy diagnostic yields and safety. Eur J Intern Med 2020; 80: 78-85
• 112 Wilson MR, Sample HA, Zorn KC. et al. Clinical metagenomic sequencing for diagnosis of meningitis and encephalitis. N Engl J Med 2019; 380 (24) 2327-2340
• 113 Mattarozzi K, Cretella L, Guarino M, Stracciari A. Minimal hepatic encephalopathy: follow-up 10 years after successful liver transplantation. Transplantation 2012; 93 (06) 639-643
• 114 Tryc AB, Pflugrad H, Goldbecker A. et al. New-onset cognitive dysfunction impairs the quality of life in patients after liver transplantation. Liver Transpl 2014; 20 (07) 807-814
• 115 Hopp AE, Dirks M, Petrusch C. et al. Hepatic encephalopathy is reversible in the long term after liver transplantation. Liver Transpl 2019; 25 (11) 1661-1672
• 116 Rovira A, Córdoba J, Sanpedro F, Grivé E, Rovira-Gols A, Alonso J. Normalization of T2 signal abnormalities in hemispheric white matter with liver transplant. Neurology 2002; 59 (03) 335-341
• 117 Campagna F, Montagnese S, Schiff S. et al. Cognitive impairment and electroencephalographic alterations before and after liver transplantation: what is reversible?. Liver Transpl 2014; 20 (08) 977-986
• 118 Lewis MB, Howdle PD. Cognitive dysfunction and health-related quality of life in long-term liver transplant survivors. Liver Transpl 2003; 9 (11) 1145-1148
• 119 Pflugrad H, Schrader AK, Tryc AB. et al. Long-term calcineurin inhibitor therapy and brain function in patients after liver transplantation. Liver Transpl 2018; 24 (01) 56-66
• 120 Weiss N, Thabut D. Neurological complications occurring after liver transplantation: role of risk factors, hepatic encephalopathy, and acute (on chronic) brain injury. Liver Transpl 2019; 25 (03) 469-487
• 121 Dirks M, Pflugrad H, Tryc AB. et al. Impact of immunosuppressive therapy on brain derived cytokines after liver transplantation. Transpl Immunol 2020; 58: 101248
• 122 Schmitz B, Pflugrad H, Tryc AB. et al. Brain metabolic alterations in patients with long-term calcineurin inhibitor therapy after liver transplantation. Aliment Pharmacol Ther 2019; 49 (11) 1431-1441
• 123 Goede LL, Pflugrad H, Schmitz B. et al. Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation. PLoS One 2019; 14 (09) e0222934
• 124 Palacín M, Coto E, Llobet L, Pacheu-Grau D, Montoya J, Ruiz-Pesini E. FK506 affects mitochondrial protein synthesis and oxygen consumption in human cells. Cell Biol Toxicol 2013; 29 (06) 407-414
• 125 Illsinger S, Janzen N, Lücke T. et al. Cyclosporine A: impact on mitochondrial function in endothelial cells. Clin Transplant 2011; 25 (04) 584-593
• 126 Illsinger S, Göken C, Brockmann M. et al. Effect of tacrolimus on energy metabolism in human umbilical endothelial cells. Ann Transplant 2011; 16 (02) 68-75
• 127 Pflugrad H, Nösel P, Ding X. et al. Brain function and metabolism in patients with long-term tacrolimus therapy after kidney transplantation in comparison to patients after liver transplantation. PLoS One 2020; 15 (03) e0229759
• 128 Lai CH, Cheng PY, Chen YY. Liver cirrhosis and risk of intracerebral hemorrhage: a 9-year follow-up study. Stroke 2011; 42 (09) 2615-2617
• 129 Berry K, Rubin JB, Lai JC. Osmotic demyelination syndrome in hospitalized patients with cirrhosis: analysis of the National Inpatient Sample (NIS). J Clin Gastroenterol 2022; 56 (03) 280-283
• 130 Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol 2017; 112 (01) 18-35
• 131 Sarin SK, Choudhury A, Sharma MK. et al; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int 2019; 13 (04) 353-390
• 132 Jalan R, Saliba F, Pavesi M. et al; CANONIC study investigators of the EASL-CLIF Consortium. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014; 61 (05) 1038-1047
• 133 O'Leary JG, Reddy KR, Garcia-Tsao G. et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology 2018; 67 (06) 2367-2374
• 134 McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of Kings's College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol 2010; 53 (03) 492-499
• 135 Kitzberger R, Funk GC, Holzinger U. et al. Severity of organ failure is an independent predictor of intracranial hypertension in acute liver failure. Clin Gastroenterol Hepatol 2009; 7 (09) 1000-1006
• 136 Clemmesen JO, Larsen FS, Kondrup J, Hansen BA, Ott P. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999; 29 (03) 648-653
• 137 Slack AJ, Auzinger G, Willars C. et al. Ammonia clearance with haemofiltration in adults with liver disease. Liver Int 2014; 34 (01) 42-48
• 138 Warrillow S, Fisher C, Bellomo R. Correction and control of hyperammonemia in acute liver failure: the impact of continuous renal replacement timing, intensity, and duration. Crit Care Med 2020; 48 (02) 218-224
• 139 Larsen FS, Hansen BA, Ejlersen E. et al. Cerebral blood flow, oxygen metabolism and transcranial Doppler sonography during high-volume plasmapheresis in fulminant hepatic failure. Eur J Gastroenterol Hepatol 1996; 8 (03) 261-265
• 140 Thayapararajah SW, Gulka I, Al-Amri A, Das S, Young GB. Acute fulminant hepatic failure, encephalopathy and early CT changes. Can J Neurol Sci 2013; 40 (04) 553-557
• 141 Scheuermann K, Thiel C, Thiel K. et al. Correlation of the intracranial pressure to the central venous pressure in the late phase of acute liver failure in a porcine model. Acta Neurochir Suppl (Wien) 2012; 114: 387-391
• 142 Conn HBJ. Quantifying the severity of hepatic encephalopathy. In: Conn HBJ. ed., Hepatic Encephalopathy: Syndromes and therapies. Bloomington, IL: Medi-Ed Press; 1994
• 143 Thakur PK, Dixit VK, Shukla SK, Thakur R, Mitra T, Yadav DP. Correlation between frequency of flaps in asterixis and severity of the liver disease in patients with hepatic encephalopathy. J Clin Diagn Res 2019; 13 (08) OC11-OC13
• 144 CollaMachado PE, Pappolla A, Balian NR. et al. [Early central neurologic complications after heart transplantation are associated with higher intra-hospital mortality]. Medicina (B Aires) 2020; 80 (04) 324-328
• 145 Bartynski WS, Tan HP, Boardman JF, Shapiro R, Marsh JW. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008; 29 (05) 924-930
• 146 Yavuz G, Heck S, Sienel W. et al. Posterior reversible encephalopathy syndrome after lung transplantation: risk factors and management. Clin Transplant 2023; 37 (01) e14850